for optimization/compliance and validation for Pharma manufacturing. Interface directly with Corporate Account Managers to present... Basic Qualifications: HS Diploma 3 years of practical experience in Pharma or adjacent Life Science production (e.g...
Description: The candidate will be responsible for leveraging computational methods to advance drug discovery from target identification through clinical strategy design. While the focus will be on utilizing predictive modelling to suppor...
About Forge Forge, a member of Ajinomoto Bio-Pharma Services, is a gene therapy development engine, focused... the gene therapy community: scientists, physicians, biotech/pharma companies, and patient groups. We bring expertise in...
While inviting suggestions of public, Sebi has released a consultation paper on the review of issue and listing of securitised debt instruments. These relate to the ticket size, offer period, definition of debt, rights of investors, among other criteria Continue Reading »
With Q2 results due on November 8, analysts forecast a strong performance for State Bank of India, projecting a 14.5% net profit increase. The stock target is set at ₹874, supported by solid credit growth expectations. Continue Reading »
IPO News Today Live Updates on November 2, 2024: Explore the latest on initial public offerings (IPOs), featuring insights into newly public companies and market trends. Get the details on upcoming IPOs, pricing strategies, and how these new stocks perform on the exchange, providing crucial information for investors and market watchers Continue Reading »
Swiggy IPO will launch on November 6, aiming to raise ₹11,327 crore. The price band is set at ₹371- ₹390 per share, with a minimum investment of ₹14,820. Prominent investors have bid over $15 billion, significantly exceeding the reserved portion. Continue Reading »
The Indian stock market saw a 25% rise last Samvat, but investor Shankar Sharma warns of a challenging year ahead with moderate returns. He suggests caution due to high valuations and weak earnings, while expressing optimism for the Chinese market. Continue Reading »
India's Nifty 50 ended its four-week losing streak with a 0.51% gain but faced significant selloff in October. Sumeet Bagadia recommends ONGC, Mahindra & Mahindra, and ABFRL as stocks to buy, with specific targets and stop-loss levels outlined for each. Continue Reading »